+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Middle East & Africa Home Healthcare Market Size, Share & Trends Analysis Report By Components (Equipment, Services), By Indication (Maternal Disorders, Cancer), By Country, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 80 Pages
  • February 2024
  • Region: Africa, Middle East
  • Grand View Research
  • ID: 5943891
The Middle East and Africa home healthcare market size is anticipated to reach USD 9.84 billion by 2030, registering a CAGR of 5.38% from 2024 to 2030. The increasing incidences of chronic diseases and rising demand for cost-effective alternatives to hospitalization are the major factors contributing to market growth. According to the World Health Organization (WHO), chronic diseases cause 1.7 million deaths yearly in the Eastern Mediterranean region. Also, the number of individuals with chronic diseases like diabetes is anticipated to reach 47 million by 2045. The rising geriatric population has increased demand for home healthcare services, such as skilled nursing, physical therapy, and assistance with everyday life activities, and this is anticipated to drive market growth.

Furthermore, rapid technological advancements, such as integrating telemedicine and remote patient monitoring solutions, offer a comprehensive approach to managing patient health outside traditional hospital settings and potentially transform home healthcare. The Middle East's governments have been actively promoting home healthcare to improve patient care and lessen the burden on conventional healthcare institutions. For instance, in 2023, the National Center for Privatization & PPP and the Ministry of Health Saudi Arabia collaborated to launch the Expressions of Interest (EOI) for home healthcare, long-term care, and medical rehabilitation projects in the Eastern Region and Riyadh.

Middle East & Africa Home Healthcare Market Report Highlights

  • The services component segment dominated the market with a share of 84.1% in 2023 due to being a more affordable option for hospitalization and institutional care
  • In the component segment, equipment is expected to grow at the fastest CAGR from 2024 to 2030. Advanced technological innovations in products that facilitate prompt and precise diagnosis are anticipated to drive growth in the diagnostic equipment sector
  • The diabetes & kidney disorders segment accounted for a significant share of the indication segment in 2023 owing to the rising prevalence of diabetes in the region, leading to increasing incidences of disorders related to kidneys. Such conditions have a substantial impact on patients, rendering home healthcare necessary
  • The mobility disorder sector in the indication segment is anticipated to witness the fastest growth over the forecast period
  • In January 2024, Burjeel Holdings and E& Enterprise announced two collaborations to transform healthcare in the UAE and beyond. These include the introduction of a strategic memorandum of agreement (MoU) and launching telemedicine services. The collaboration emphasizes achieving sustainable healthcare goals in managing chronic diseases, advanced telemedicine, and remote patient care monitoring systems


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Component
1.2.2. Indication
1.2.3. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Component outlook
2.2.2. Indication outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Middle East and Africa Home Healthcare Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising prevalence of chronic diseases
3.2.1.2. Technological advancements in ablation devices
3.2.1.3. Rising geriatric population
3.2.1.4. Government initiatives
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulations
3.2.2.2. Scarcity of skilled home healthcare service professionals
3.3. Middle East and Africa Home Healthcare Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.2.4. Social landscape
3.3.2.5. Legal landscape
3.3.2.6. Environmental landscape
Chapter 4. Middle East and Africa Home Healthcare Market: Component Estimates & Trend Analysis
4.1. Component Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Middle East and Africa Home Healthcare Market by Component Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
4.4.1. Equipment
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.1. Therapeutic
4.4.1.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.1.2. Home respiratory equipment
4.4.1.1.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.1.3. Insulin delivery market
4.4.1.1.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.1.4. Home IV pumps
4.4.1.1.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.1.5. Home dialysis equipment
4.4.1.1.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.1.6. Other therapeutic equipment
4.4.1.1.1.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.2. Diagnostics
4.4.1.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.2.2. Diabetic care unit
4.4.1.1.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.2.3. BP monitors
4.4.1.1.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.2.4. Multi para diagnostic monitors
4.4.1.1.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.2.5. Home pregnancy and fertility kits
4.4.1.1.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.2.6. Apnea and sleep monitors
4.4.1.1.2.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.2.7. Holter monitors
4.4.1.1.2.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.2.8. Heart rate meters (include pacemakers)
4.4.1.1.2.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.2.9. Others
4.4.1.1.2.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.3. Mobility assist
4.4.1.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.3.2. Wheel chair
4.4.1.1.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.3.3. Home medical furniture
4.4.1.1.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.1.3.4. Walking assist devices
4.4.1.1.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Services
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.1.1. Skilled nursing services
4.4.2.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.1.1.2. Physician primary care
4.4.2.1.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.1.1.3. Nursing care
4.4.2.1.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.1.1.4. Physical/occupational/speech therapy
4.4.2.1.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.1.1.5. Nutritional support
4.4.2.1.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.1.1.6. Hospice & palliative
4.4.2.1.1.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.1.1.7. Other skilled nursing services
4.4.2.1.1.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.1.2. Unskilled nursing services
4.4.2.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Middle East and Africa Home Healthcare Market: Indication Estimates & Trend Analysis
5.1. Indication Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Middle East and Africa Home Healthcare Market by Indication Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
5.4.1. Cardiovascular disorder & hypertension
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Diabetes & kidney disorders
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Neurological & mental disorders
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Respiratory disease & COPD
5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.5. Maternal disorders
5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.6. Mobility disorders
5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.7. Cancer
5.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.8. Wound care
5.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.9. Others
5.4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Middle East and Africa Home Healthcare Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Middle East and Africa Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.5. South Africa
6.5.1. Key country dynamics
6.5.2. Regulatory framework/ reimbursement structure
6.5.3. Competitive scenario
6.5.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Saudi Arabia
6.6.1. Key country dynamics
6.6.2. Regulatory framework/ reimbursement structure
6.6.3. Competitive scenario
6.6.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Oman
6.7.1. Key country dynamics
6.7.2. Regulatory framework/ reimbursement structure
6.7.3. Competitive scenario
6.7.4. Oman market estimates and forecasts 2018 to 2030 (USD Million)
6.8. Egypt
6.8.1. Key country dynamics
6.8.2. Regulatory framework/ reimbursement structure
6.8.3. Competitive scenario
6.8.4. Egypt market estimates and forecasts 2018 to 2030 (USD Million)
6.9. UAE
6.9.1. Key country dynamics
6.9.2. Regulatory framework/ reimbursement structure
6.9.3. Competitive scenario
6.9.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
6.10. Rest of Middle East and Africa
6.10.1. Key country dynamics
6.10.2. Regulatory framework/ reimbursement structure
6.10.3. Competitive scenario
6.10.4. Rest of Middle East and Africa market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company heat map analysis, 2023
7.4. Company Profiles
7.4.1. Koninklijke Philips N.V.
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Product benchmarking
7.4.1.4. Strategic initiatives
7.4.2. Omron Healthcare, Inc.
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Product benchmarking
7.4.2.4. Strategic initiatives
7.4.3. Air Liquide
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Product benchmarking
7.4.3.4. Strategic initiatives
7.4.4. Amana Healthcare
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Product benchmarking
7.4.4.4. Strategic initiatives
7.4.5. B. Braun SE
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Product benchmarking
7.4.5.4. Strategic initiatives
7.4.6. Medtronic
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Product benchmarking
7.4.6.4. Strategic initiatives
7.4.7. Manzil Healthcare Services
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Product benchmarking
7.4.7.4. Strategic initiatives
7.4.8. Al Tadawi Medical Centre
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Product benchmarking
7.4.8.4. Strategic initiatives
7.4.9. NMC Healthcare
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Product benchmarking
7.4.9.4. Strategic initiatives
7.4.10. Abeer Medical
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Product benchmarking
7.4.10.4. Strategic initiatives
7.4.11. Davita Inc.
7.4.11.1. Company overview
7.4.11.2. Financial performance
7.4.11.3. Product benchmarking
7.4.11.4. Strategic initiatives
7.4.12. CARDINAL HEALTH
7.4.12.1. Company overview
7.4.12.2. Financial performance
7.4.12.3. Product benchmarking
7.4.12.4. Strategic initiatives
7.4.13. Sunrise Medical
7.4.13.1. Company overview
7.4.13.2. Financial performance
7.4.13.3. Product benchmarking
7.4.13.4. Strategic initiatives
7.4.14. GE Healthcare
7.4.14.1. Company overview
7.4.14.2. Financial performance
7.4.14.3. Product benchmarking
7.4.14.4. Strategic initiatives
7.4.15. F. Hoffmann-La Roche Ltd
7.4.15.1. Company overview
7.4.15.2. Financial performance
7.4.15.3. Product benchmarking
7.4.15.4. Strategic initiatives
7.4.16. Linde plc
7.4.16.1. Company overview
7.4.16.2. Financial performance
7.4.16.3. Product benchmarking
7.4.16.4. Strategic initiatives
7.4.17. Mediclinic Middle East
7.4.17.1. Company overview
7.4.17.2. Financial performance
7.4.17.3. Product benchmarking
7.4.17.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 Middle East and Africa home healthcare market, by region, 2018 - 2030 (USD Million)
Table 3 Middle East and Africa home healthcare market, by component, 2018 - 2030 (USD Million)
Table 4 Middle East and Africa home healthcare market, by indication, 2018 - 2030 (USD Million)
Table 5 South Africa home healthcare market, by component, 2018 - 2030 (USD Million)
Table 6 South Africa home healthcare market, by indication, 2018 - 2030 (USD Million)
Table 7 Saudi Arabia home healthcare market, by component, 2018 - 2030 (USD Million)
Table 8 Saudi Arabia home healthcare market, by indication, 2018 - 2030 (USD Million)
Table 9 Oman home healthcare market, by component, 2018 - 2030 (USD Million)
Table 10 Oman home healthcare market, by indication, 2018 - 2030 (USD Million)
Table 11 Egypt home healthcare market, by component, 2018 - 2030 (USD Million)
Table 12 Egypt home healthcare market, by indication, 2018 - 2030 (USD Million)
Table 13 UAE home healthcare market, by component, 2018 - 2030 (USD Million)
Table 14 UAE home healthcare market, by indication, 2018 - 2030 (USD Million)
Table 15 Rest of Middle East and Africa Middle East and Africa home healthcare market, by component, 2018 - 2030 (USD Million)
Table 16 Rest of Middle East and Africa Middle East and Africa home healthcare market, by indication, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in Middle East and Africa
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Middle East and Africa home healthcare market: market outlook
Fig. 10 Middle East and Africa home healthcare competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 Middle East and Africa home healthcare market driver impact
Fig. 16 Middle East and Africa home healthcare market restraint impact
Fig. 17 Middle East and Africa home healthcare market strategic initiatives analysis
Fig. 18 Middle East and Africa home healthcare market: Component movement analysis
Fig. 19 Middle East and Africa home healthcare market: Component outlook and key takeaways
Fig. 20 Equipment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Therapeutic market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Home respiratory equipment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Insulin delivery market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Home iv pumps market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Home dialysis equipment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Other therapeutic equipment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Diabetic care unit market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 BP monitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Multi para diagnostic monitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Home pregnancy and fertility kits market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Apnea and sleep monitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Holter monitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Heart rate meters (include pacemakers) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Other market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Mobility assist market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Wheel chair market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Home medical furniture market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Walking assist devices market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Skilled nursing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Physician primary care market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Nursing care market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Physical/occupational/speech therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Nutritional support market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Hospice & palliative market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Other skilled nursing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Unskilled nursing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Middle East and Africa home healthcare market: Indication movement Analysis
Fig. 50 Middle East and Africa home healthcare market: Indication outlook and key takeaways
Fig. 51 Cardiovascular disorder & hypertension market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Diabetes & kidney disorders market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Neurological & mental disorders market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Respiratory disease & COPD market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Maternal disorders market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Mobility disorders market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Wound care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Middle East and Africa home healthcare: Regional movement analysis
Fig. 61 Middle East and Africa home healthcare: Regional outlook and key takeaways
Fig. 62 Middle East and Africa home healthcare market share and leading players
Fig. 63 Middle East and Africa SWOT
Fig. 64 South Africa
Fig. 65 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Saudi Arabia
Fig. 67 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Oman
Fig. 69 Oman market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Egypt
Fig. 71 Egypt market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 UAE
Fig. 73 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Rest of Middle East and Africa
Fig. 75 Rest of Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)

Companies Mentioned

  • Koninklijke Philips N.V.
  • Omron Healthcare, Inc.
  • Air Liquide
  • Amana Healthcare
  • B. Braun SE
  • Medtronic
  • Manzil Healthcare Services
  • Al Tadawi Medical Centre
  • NMC Healthcare
  • Abeer Medical
  • Davita Inc.
  • CARDINAL HEALTH
  • Sunrise Medical
  • GE Healthcare
  • F. Hoffmann-La Roche Ltd
  • Linde plc
  • Mediclinic Middle East

Methodology

Loading
LOADING...

Table Information